EUROPEAN TRAINING CENTRE

Nephrology Service, Dialysis Unit
University Hospital Reina Sofía
Cordoba, Spain

 

 

 

Peer Reviewed Publications in International Journals (only English) 2000-2002

PUBLICATIONS

Effect of uremia and dialysis modality on mononuclear cell aopoptosis.
Martin-Malo A, Carracedo J, Ramirez R, Rodriguez-Benot A, Soriano S, Rodriguez M, Aljama P.
Journal of the American Society of Nephrology 11:936-942, 2000.

Hepatitis C virus in hemodialysis patients.
Espinosa M, Marin-Malo A, Aljama P.
Kidney International 58:462, 2000

High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied.
Espinosa M, Martin-Malo A, Alvarez de Lara A, Soriano S, Aljama P.
Clinical Nephrology 54:151-156, 2000.

Apoptosis en linfocitos de pacientes con insuficiencia renal crónica
Soriano S, Santos JM, Aljama P.
Revista Portuguesa de Nefrología e Hipertensâo 14:209-215, 2000.

Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response.
Espinosa M, Rodriguez M, Martin-Malo A, Alvarez de Lara A, Gonzalez R, López-Rubio F, de la Mata M, Aljama P.
Clinical Nephrology 55:220-226, 2001.

La activación celular y apoptosis como marcadores de la inflamación inducida por la hemodialisis.
Carracedo J, Ramirez R, Madueño JA, Soriano S, Rodriguez-Benot A, Rodriguez M, Martin-Malo A, Aljama P.
Nefrología 21 (Suppl 1):S40-S44, 2001.

Blood pressure and body water distribution in chronic renal failure patients.
Alvarez de Lara A, Martin-Malo A, Espinosa M, Rodriguez-Benot A, Aljama P.
Nephrology Dialysis Transplantation 16 (Suppl 1):S94-S97, 2001.

Practical guidelines for the use of NESP in treating renal anaemia.
Aljama P, Bommer J, Canaud B, Carrera F, Eckardt KU, Hörl WH, Krediet RT, Locatelli F, Macdougall IC, Wikström B.
Nephrology Dialysis Transplantation 16 (Suppl 3):S22-S28, 2001.

Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients.
Espinosa M, Martin-Malo A, Alvarez de Lara A, Aljama P.
Nephrology Dialysis Transplantation 16:1669-1674, 2001.

Role of adhesion molecules in monocelular cell apoptosis induced by cuprophan hemodialysis membranes.
Carracedo J, Ramirez R, Martin-Malo A, Rodriguez M, Madueño JA, Aljama P.
Nephron 89:186-193, 2001.

A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease.
Marin R, Ruilope LM, Aljama P, Aranda P, Segura J, Diez J.
Journal of Hypertension 19:1871-1876, 2001.

Assessment of the length of each hemodialysis session by on-line dialysate urea monitoring.
Herandez-Herrera G, Martin-Malo A, Rodriguez M, Aljama P.
Nephron 89:37-42, 2001.

Alfa-interferon therapy increases serum b2-microglobulin levels in hemodialysis patients.
Espinosa M, Martin-Malo A, Alvarez de Lara A, Navarro MD, Aljama P.
Clinical Nephrology 56:378-381, 2001.

Utilización de fármacos en insuficiencia renal. Fármacos contraindicados (contraindicación absoluta y relativa).
García-Criado EI, Aljama P.
Nefrología Extrahospitalaria 2:16-19, 2002.

Performance liquid test as a cause for sudden deaths of dialysis patients: perfluorohydro-carbon, a previously unrecognized hazard for dialysis patients.
Canaud B, Aljama P, Locatelli F, Tielemans C, Gasparovic V, Hörl W, Baldamus C, Gutierrez A, Henrich W, Lamiere N.
Nephrology Dialysis Transplantation 17:545-548, 2002.

The effect of LPS, uremia, and haemodialysis membrane exposure on CD14 expression in mononuclear cells and its relation to apoptosis.
Carracedo J, Ramirez R, Martin-Malo A, Rodriguez M, Aljama P.
Nephrology Dialysis Transplantation 17:428-434, 2002.

Utilización de fármacos en la insuficiemcia renal.
García-Criado EI, Aljama P.
Nefrología 21 (Suppl 5):S54-S57, 2002.

Cell apoptosis and hemodialysis-induced inflammation.
Carracedo J, Ramirez R, Madueño JA, Soriano S, Rodriguez-Benot A, Rodriguez M, Martin-Malo A, Aljama P.
Kidney International 61 (Suppl 80):S89-S93, 2002.

Sterilization procedures and biocompatibility.
Rodriguez-Benot A, Santamaría R, Martin-Malo A, Aljama P.
Contributions to Nephrology 137:138-145, 2002.

Dialysate purity: A must.
Ramirez R, Carracedo J, Martin-Malo A, Rodriguez M, Aljama P.
Contributions to Nephrology 137:325-331, 2002.

Natural history of acute HCV infection in hemodialysis patients
Espinosa M, Martin-Malo A, Alvarez de Lara MA, Gonzalez R, Rodriguez M, Aljama P.
Clinical Nephrology 58:143-150, 2002.

Caspase-3-dependent pathway mediates apoptosis of human mononuclear cells induced by cellulosic hemodialyisis membranes.
Carracedo J, Ramirez R, Soriano S, Martin-Malo A, Rodriguez M, Aljama P.
Nephrology Dialysis Transplantation (in press)

Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment.
F Locatelli, J Bommer, GM London, A Martin-Malo, C Wanner, M Yaqoob, C Zoccali.
Nephrology Dialysis Transplantation 16: 459-468, 2001.

Protein intake, control of serum phosphorus, and relatively low levels of parathyroid hormone in elderly hemodialysis patients.
V Lorenzo, M Martin, M Rufino, A Jimenez, A Martin-Malo, E Sanchez, D Hernandez, M Rodriguez, A Torres.
American Journal of Kidney Disease 37: 1260-1266, 2001.